Product Information
DISOPYRAMIDE 100 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.8005 per EA under NDC 59762038601. Its NADAC has been published 304 times since Jun 12, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762038601
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DISOPYRAMIDE PHOSPHATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017447FDA Approved
Before 1982
TE Code
AB
On Market Since
4/23/2019
Pharmacological Classes
Price Statistics
The NADAC for DISOPYRAMIDE 100 MG CAPSULE has been published 304 times since Jun 12, 2019, and over the history we have for it it has declined 49.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8005 per EA |
|---|---|
| All-time high | $1.7116 (Dec 16, 2020) |
| All-time low | $0.6706 (Nov 20, 2024) |
| 52-week high | $1.1178 |
| 52-week low | $0.6765 |
| Median price | $1.2971 |
| Average price | $1.2180 |
| Largest weekly change | +30.7% (Oct 20, 2021) |
| Weeks tracked | 304 |
| Tracking since | Jun 12, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
disopyramide phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DISOPYRAMIDE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DISOPYRAMIDE 100 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $0.8005 per EA (NDC 59762038601), effective Sep 30, 2026.
How has the price of DISOPYRAMIDE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DISOPYRAMIDE 100 MG CAPSULE has declined 49.3%. It has been tracked across 304 weekly CMS publications since Jun 12, 2019.
What are the highest and lowest recorded NADAC prices for DISOPYRAMIDE 100 MG CAPSULE?
Since Jun 12, 2019, the NADAC for DISOPYRAMIDE 100 MG CAPSULE has ranged from a low of $0.6706 (Nov 20, 2024) to a high of $1.7116 (Dec 16, 2020), with a median of $1.2971 per EA.
Are there cheaper alternatives to DISOPYRAMIDE 100 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DISOPYRAMIDE 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DISOPYRAMIDE 100 MG CAPSULE?
DISOPYRAMIDE 100 MG CAPSULE (NDC 59762038601) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.